HCA Healthcare, Inc. $HCA Stock Position Boosted by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,949 shares of the company’s stock after purchasing an additional 1,480 shares during the period. Rakuten Investment Management Inc.’s holdings in HCA Healthcare were worth $11,632,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the business. BlackRock Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $5,069,974,000. Wellington Management Group LLP raised its position in shares of HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares in the last quarter. Darsana Capital Partners LP lifted its stake in HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after purchasing an additional 350,000 shares during the last quarter. Legal & General Group Plc acquired a new position in HCA Healthcare in the second quarter worth $410,992,000. Finally, Jupiter Topco LLC bought a new stake in HCA Healthcare during the second quarter valued at $371,138,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Hospitals and health insurers rallied after Democrats’ midterm gains, a sector-wide move that likely helped lift HCA. The coverage does not specify which policy changes investors expect. Article: Health insurers, hospitals rally after sweeping midterm win for Democrats
• Positive Sentiment: HCA’s quarterly results beat expectations: adjusted earnings were $7.22 per share versus a $6.65 consensus estimate, and revenue was $19.85 billion versus $19.33 billion. Revenue grew 3.6% year over year. Article: Why HCA Healthcare is a top growth stock for the long term
• Positive Sentiment: Wells Fargo raised its price target on HCA, while Truist reaffirmed its Buy rating and lifted its target to $510 from $495. These moves signal continued analyst support. Article: HCA Healthcare stock gets price target boost from Wells Fargo Article: Truist reaffirms Buy rating
• Positive Sentiment: HCA Houston Healthcare Northwest introduced next-generation robotic-assisted surgical technology, which may strengthen its service offering and competitive position. Article: HCA Houston Healthcare Northwest introduces robotic-assisted surgical technology
• Neutral Sentiment: HCA is planning a $300 million hospital in Cape Coral, with $31 million in city incentives. The project supports expansion, though its investment and execution costs may take time to translate into returns. Article: Cape Coral lands $300 million HCA hospital
• Neutral Sentiment: HCA launched a senior-notes offering; the article listing does not provide details on terms or intended use of proceeds, so the effect on leverage is unclear. Article: HCA Healthcare launches senior notes offering
• Negative Sentiment: Uninsured-patient costs reportedly shifted by $400 million in HCA’s third-quarter payer mix, a potential headwind to profitability. Article: HCA Q3 revenue by payer as uninsured shift costs $400M
• Negative Sentiment: Reports of data breaches involving HCA raise potential privacy, regulatory, and reputational concerns; the article listing does not specify the impact. Article: Data breaches announced by HCA Healthcare
• Negative Sentiment: A law firm announced an investigation into claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but it can create legal and reputational uncertainty. Article: Pomerantz investigates claims on behalf of HCA investors

Wall Street Analyst Weigh In

HCA has been the topic of several recent research reports. Leerink Partners reissued an “outperform” rating and issued a $492.00 price target on shares of HCA Healthcare in a report on Friday, September 18th. Barclays increased their target price on HCA Healthcare from $387.00 to $401.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 29th. Morgan Stanley reduced their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Robert W. Baird upped their price target on shares of HCA Healthcare from $393.00 to $409.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 28th. Finally, JPMorgan Chase & Co. cut their price objective on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research report on Thursday, August 20th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $480.13.

HCA Healthcare Trading Up 10.3%

Shares of HCA Healthcare stock opened at $510.31 on Thursday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The company has a market cap of $106.60 billion, a P/E ratio of 16.91, a P/E/G ratio of 1.55 and a beta of 1.11. The stock has a 50-day moving average price of $440.51 and a 200 day moving average price of $444.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.65 by $0.57. The business had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. HCA Healthcare’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period last year, the company earned $6.96 earnings per share. On average, equities analysts forecast that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.34%.

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.